1. Whole-cell, high-threshold, voltage-dependent calcium currents (ICa) were enhanced in acutely dissociated, capsaicin-sensitive dorsal root ganglion neurones from diabetic Bio Bred/Worchester (BB/W) rats, compared with those from age-matched, non-diabetic controls. The magnitude of the enhancement increased with the duration of diabetes, and reached significance at diabetic durations of 6 months (diabetic: 6-3 + 0 4 nA; current density (CD), 157 + 12 pA pF'; means + S.E.M., n= 9, P< 0 01; control: 3-9 + 0-6 nA; CD, 116 + 11 pA pF'; n = 18) and 8 months (diabetic: 7-6 + 0 4 nA; CD, 177 + 25 pA pFY; n = 11, P < 0005; control: 5-1 + 0 5 nA; CD, 111 + 26 pA pF-'; n = 15). Low-threshold, voltage-dependent Ica were also enhanced in neurones from animals diabetic for 8 months (diabetic: 2-5 + 0 7 nA, n = 4, P< 0 05; control: 0'7 + 0 5 nA, n = 6).
Diabetic neuropathy is the most common form of peripheral neuropathy in the Western world, with metabolic, functional and morphological changes in peripheral nerves documented in both human and animal models of diabetes mellitus (Behse, Buchtal & Carlsen, 1977; Brismar, 1983; Sima et al. 1988) . Despite this, there is relatively little data on the effect of diabetes on neuronal function at the cellular level. Abnormalities described in peripheral nerves of animal and human diabetics include decreased conduction velocity, morphological changes such as axonal swelling, axo-glial dysfunction, atrophy and nerve fibre loss (Sima & Brismar, 1985) , and metabolic alterations such as decreased myo-inositol tissue levels, decreased Na+,K+-ATPase activity, and mitochondrial membrane dysfunction linked to the production of sorbitol by the polyol pathway in response to hyperglycaemia . Decreased Na+,K+-ATPase activity has also been reported to occur in both superior cervical and dorsal root ganglia (DRG) (Green, King, Thomas & Baron, 1986) , suggesting that similar pathophysiological mechanisms may be operative in autonomic neuropathy. Decreased myo-inositol levels have been associated with decreased production of intracellular second messengers such as inositol trisphosphate and diacylglycerol ). In both human and animal studies, treatment with oral aldose reductase inhibitors or dietary myo-inositol supplementation have been shown to reverse some of these metabolic changes, and improve the nerve conduction defect Sima et al. 1988; Sima, Prashar, Zhang, Chakrabarti & Greene, 1990) .
t To whom correspondence should be addressed. 3939 Considerable evidence suggests that metabolic overstimulation by cytosolic calcium ([Ca2+] i) may contribute to neuronal cell injury (Nicotera, Bellomo & Orrenius, 1992 ).
An important contribution to [Ca2+] i in excitable tissues is made by the entry of external Ca2+ through voltagedependent calcium channels (Thayer & Miller, 1990) . Indirect evidence suggests that calcium signalling is abnormal in cardiac myocytes (Nobe, Aomine, Arita, Ito & Takaki, 1990) , vascular smooth muscle (Kamata, Miyata & Kasuya, 1988) , and other tissues (Levy, Gavin & Sowers, 1994 ) from diabetic animals. Therefore, the goal of the present study was to examine directly whether calcium influx via voltagedependent calcium channels was altered in primary afferent sensory neurones in diabetes mellitus, and to evaluate the effect of an aldose reductase inhibitor on any observed alteration in calcium influx. We utilized the Bio Bred/Worchester (BB/W) rat, which developes an immunologically mediated type of diabetes that has morphological and metabolic characteristics similar to human type I diabetes mellitus (Brismar, 1983 ).
These studies have been presented in preliminary form (Hall, Mann & Wiley, 1993a Research and Training Center. After the onset of diabetes, as determined by the onset of glucosuria during daily urine glucose monitoring, ultralente insulin (0A4-3 0 i.u. day-' subcutaneous injection; Novo Nordisk, Princeton, NJ, USA) was administered to maintain hyperglycaemic blood glucose levels between 16 and 25 mmol F' (300-450 mg dl-') and prevent ketoacidosis. Body weight, urinary glucose and ketone bodies were monitored daily and the insulin dose titrated as described previously (Sima, 1983) . Blood glucose levels were monitored daily until the desired plasma glucose levels were achieved, and monthly thereafter. Sciatic nerve conduction velocity was measured on the day before animals were killed (Sima et al. 1990 ). Preparation of acutely dissociated DRG neurones Isolated, acutely dissociated DRG neurones were aseptically prepared from the three groups of rats outlined above using a technique similar to that described previously (Gross, Wiley, Ryan-Jastrow & Macdonald, 1990) . Rats were killed by inhalation of 100% CO2, the spinal column was removed, and the thoracic and lumbar DRGs identified and extracted. The DRGs were trimmed, minced, incubated with 2 ml 0 3% collagenase Type II (Sigma) and 0-1 % trypsin Type I (bovine; Sigma), then triturated and centrifuged. Enzymes were prepared in minimal essential medium (MEM; Gibco) supplemented with 16 mm NaHCO3 and 28 mm glucose (320 mosmol kg'). The isolated DRGs were resuspended in supplemented MEM containing 10% horse serum (Gibco) without nerve growth factor, and plated onto poly-Llysine-coated glass coverslips. The coverslips were incubated in 93% air-7% CO2 at 370C, and recordings performed at room temperature between 1P5 to 7 h after plating. Whole-cell voltage-clamp recordings Voltage-clamp recordings using the whole-cell variant of the patch-clamp technique (Hamill, Marty, Neher, Sakmann & Sigworth, 1981) those used to depolarize the cell were digitally subtracted from Ica To control for the possibility that alterations in Ica between the control and diabetic groups occurred simply on the basis of variations in cell size, the current density (CD; in picoamps per picofarad) was determined. Small depolarizing calibration voltage pulses (V, = +5 mV for 12 ms, or -10 mV for 100 ms; Vh = -80 mV) were performed immediately after patch rupture. Whole-cell capacitance (proportional to surface area) was calculated using the following formula:
where C is capacitance (in picofarads), A (in picofarads per millivolt) is the area under the capacitance current curve from the peak inward current to the point at which ICa is 0, and V is calibration voltage step (in millivolts). Peak inward currents were divided by the cell capacitance, and the normalized currents expressed in units of picoamps per picofarad. Current-voltage curve normalization Current-voltage (I-V) curves were generated by depolarizing neurones from a Vh of -80 mV to a VE of -110 to +90 mV in 10 mV steps (100 ms duration). The peak inward current for each depolarization step was plotted as a function of V,. The baseline was determined by a least-squares fit of the line connecting the points from -110 to -60 mV, and this line subtracted from the data points at each voltage step to create a baseline-subtracted I-V curve. The curves were averaged to produce mean + S.E.M. values at each Vc for control, diabetic and ARI-treated diabetic neurones.
Assessment of voltage dependence of steady-state inactivation Cells were depolarized to a V, of +10 mV for 100 ms from progressively more positive Vh (-90 to 0 mV by 10 mV steps). The cell was held at each Vh for 15 s prior to depolarization. Peak current amplitude at each Vh was plotted as a function of Vh, and fitted with a Boltzman curve generated with the following formula:
where ' Step is peak inward current at holding potential Vh, 'max i the maximum peak inward current elicited, 7h is holding potential in millivolts, Vm is the voltage at which half-maximal inactivation occurred, and k is the slope.
Statistical analysis
Significance was determined using analysis of variance and Student's two-tailed t test, and defined as a P value less than 0 05 (Mendenhall, 1975 Blood glucose values were elevated above 20 mmol 1-' in all diabetic rats, and ARI treatment had no effect on blood glucose levels ( (Fig. 1) . control (L), diabetic (U) and ARI-treated diabetic () animals (diabetic duration 4 months: 8 control, 8 diabetic neurones; diabetic 6 months: 18 control, 9 diabetic, 2 ARI-treated diabetic neurones; diabetic 8 months: 15 control, 11 diabetic, 9 ARI-treated diabetic neurones; ***P < 0005, ** P < 001 by ANOVA). B, I-V curves and C, steady-state inactivation curves generated as described in Methods for 10 control (0), 10 diabetic (o), and 11 ARI-treated (N, B only) neurones. (Fig. 1A) . In Fig. lB (Fig. 2A) . The magnitude of the enhancement increased with the duration of diabetes, and reached significance at diabetic durations of 6 months (control: 3-9 + 0-6 nA, n = 18; diabetic: 6-33 + 0-41 nA, n = 9, P< 001) and 8 months (control: 5*1 + 0*5 nA, n = 15; diabetic: 7-59 + 0-38 nA, n = 11, P < 0 005). by pressure ejection from micropipettes placed close to the neurone (see Methods). Application of diluent alone had no effect on the ICa amplitude. The agonist concentrations used were close to, or at the maximum level of, the published dose-response (Fox et al. 1987) , and our previous studies (Hall et al. 1993a) (Llinas et al. 1989 ). control and diabetic neurone. B, peak T currents (means + S.E.M.) in DRGs from 4 diabetic and 6 control animals aged 8-10 months (*P 0 05). C, I-V relationship of neurones that expressed T currents. I-V curves were generated as described in Methods for neurones demonstrating T currents (location of peak T currents denoted by horizontal bar). (Fig. 3A) . These currents were inactivated when the neuron was held at -40 mV, and correspond to the T-type current described previously (Fox et al. 1987) . The average magnitude of the peak T current (Fig. 3B ) was significantly greater in diabetic neurones (2-5 + 0 7 nA, n= 4) compared with controls (0 7 + 0'5 nA, n = 6). Analysis of the I-V relationship of cells that expressed T currents (Fig. 3C) did not demonstrate any shift in the voltage dependence of the peak low-threshold ICa (location denoted by horizontal bar) in diabetic neurones compared with controls.
DISCUSSION
High-threshold, voltage-dependent calcium currents were enhanced in acutely dissociated nociceptive DRGs from diabetic rats
We hypothesized that small-to medium-sized (20-38 ,um),
capsaicin-sensitive DRGs would show abnormalities early in diabetes, as there is evidence for early and preferential loss of small, unmyelinated, nociceptive nerve fibres and their corresponding cell bodies in diabetes (Sima & Brismar, 1985) . In our study, approximately 80% of DRG neurones, 23-38 jum in diameter, were responsive to capsaicin 0 1 /LM (>10% decrease in peak ICa), and thus the majority of neurones recorded were probably of nociceptive origin. Isolated, acutely dissociated DRG neurones in this size range demonstrated characteristic low-and high-threshold voltage-dependent ICa (Fox et al. 1987; Llinas et al. 1989) , which were enhanced in DRGs from diabetic BB/W rats compared with age-matched controls. The magnitude of enhancement increased with the duration of diabetes, and was not observed in diabetic animals receiving long-term treatment with the aldose reductase inhibitor WAY 121,509. The increase in ICa was not due to a bias towards recording from larger neurones in the diabetic group, since the mean cell diameter of non-diabetic and diabetic neurones was not significantly different. Current density measurements, which correct for cell size by dividing the whole-cell current by the cell capacitance (proportional to cell surface area), were also significantly higher in neurones from diabetic animals at 6 and 8 months.
The voltage dependence of the current-voltage relationship and steady-state inactivation were not altered in diabetes Alterations in current amplitude in response to noradrenaline, opiates and protein kinase A (PKA) have been correlated with shifts in the voltage dependence of activation (Bean, 1989; Doupnik & Pun, 1992) and inactivation (Gross & Macdonald, 1989) (Sima et al. 1990) . In this study, chronic oral treatment with the aldose reductase inhibitor WAY 121,509 initiated 1 week after onset of diabetes prevented the Ica enhancement observed in neurones from untreated diabetic animals. This effect was observed in neurones from animals with moderate to long duration of diabetes, suggesting that long-term ARI treatment may be of benefit in disease of long-standing duration. The decreased currents in ARItreated animals were not due to decreased availability of glucose, as the level of hyperglycaemia was comparable in the diabetic and ARI-treated groups. In the hyperglycaemic state, aldose reductase converts a significant amount of glucose into sorbitol ). Accumulation of sorbitol produced by the polyol pathway in response to hyperglycaemia has been implicated as a cause of the decreased myo-inositol and Na+,K+-ATPase levels described previously in sciatic nerves from diabetic rats (Das, Bray, Aguayo & Rasminsky, 1976; Greene et al. 1988) . Decreased myo-inositol uptake in diabetes has been linked to decreased production of inositol trisphosphate (Green et al. 1988) , diacylglycerol (Zhu & Eichberg, 1990) , and protein kinase C (PKC; Kim, Rushovich, Thomas, Uedat, Agranoff & Greene, 1991 (Gross & Macdonald, 1989; Yang & Tsien, 1993) . This discrepancy may be due to differences in endogenous PKC levels and/or activity between tissue types. Alternatively, phorbol esters may have non-specific effects independent of their action to activate PKC (Hockberger, Toselli, Swandulla & Lux, 1989) . Direct application of constitutively active PKC causes enhancement of 'Ca in DRGs (Hall, Tan, Browning & Macdonald, 1993 b) and invertebrate tissues (DeRiemer, Strong, Albert, Greengard & Kaczmarek, 1985) . Decreased cytosolic PKC levels have been described in diabetic neurones (Kim et al. 1991) ; however, in other tissues, increased PKC activity has been documented (Tanaka et al. 1991) . One possible explanation for these discrepancies in PKC activity may lie in the recent demonstration of selective activation of PKC isoforms in diabetes (Inoguchi, Battan, Handler, Spotsman, Heath & King, 1992; Tang, Parker, Beattie & Houslay, 1993) . Alternatively, alterations in other components of signal transduction that affect calcium channel function, such as guanine nucleotidebinding (G) proteins, may be present in diabetes. Houslay and colleagues (Gawler, Milligan, Spiegel, Unson & Houslay, 1987; Bushfield et al. 1990) (Kappelle, Biessels, Bravenboer, van Buren, Traber, de Wildt & Gispen, 1994) , suggesting that abnormalities in cellular calcium influx in diabetes mellitus may provide possible new targets for treatment. BEAN, B. P. (1989) . Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. Nature 340,
